INSUBCONTINENT EXCLUSIVE:
National Stock Exchange and the Bombay Stock Exchange asked Sun Pharma whether it is aware of any information that has not been announced to
the exchanges under regulation 30 of the Sebi (Obligation of Listed Entities, which has its specified securities or LODR) Regulations, 2015,
and which could explain the aforesaid movement in the trading
traders such as Ketan Parekh and Dharmesh Doshi, related party transactions by promoters and guarantees given by Sun Pharma to Suraksha
by one of the securities firm
The supporting information to the points raised in the note has been sourced from public domain and hence this information/data is already
available in the public domain
during trading, closing at Rs 483, marginally down by 0.61 per cent.
In a separate response to ET, Sun Pharma responding to the Macquarie
note, said that the company believes it is in compliance with all the legal/regulatory provisions applicable to it.
A separate mail sent by
